Related references
Note: Only part of the references are listed.A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
Nina Magnolo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial
C. Bodemer et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Seeking Similarities Rather Than Differences With Adults to Aid in Therapeutic Advancement for Children
Mara L. Becker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Use of Alternative Designs and Data Sources for Pediatric Trials
Freda Cooner et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2020)
Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives
Scott Marshall et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Meta-analysis of few small studies in orphan diseases
Tim Friede et al.
RESEARCH SYNTHESIS METHODS (2017)
Stan: A Probabilistic Programming Language
Bob Carpenter et al.
JOURNAL OF STATISTICAL SOFTWARE (2017)
Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases
Anna M. Stefanska et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Psoriasis in children
Roxanne Pinson et al.
PSORIASIS-TARGETS AND THERAPY (2016)
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation
S. F. Marshall et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
From Adaptive Licensing to Adaptive Pathways: Delivering a Flexible Life-Span Approach to Bring New Drugs to Patients
H-G Eichler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials
Richard G. B. Langley et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval
H-G Eichler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Summarizing historical information on controls in clinical trials
Beat Neuenschwander et al.
CLINICAL TRIALS (2010)
Share Paper
